DxNow is combining novel, portable bio-imaging systems with microfluidic-based consumables for life science applications leveraging exclusively licensed technologies developed in the Demirci Bio-Acoustic MEMS in Medicine Labs (BAMM Labs) at Harvard Medical School/Brigham & Women’s Hospital and Stanford Medicine.
The Future of fertility has arrived
Our initial products address significant market needs in fertility clinics and forensics labs. We are in the process of establishing and expanding our commercialization efforts worldwide through key geographically-specific distribution partners.
Founded in 2013, DxNow is a privately-held Delaware C corporation whose corporate headquarters and primary research and development labs are located in Montgomery County, Maryland. This location offers close proximity to Washington, DC, the USFDA, USPTO, NIH, CMS and other agencies relevant to DxNow’s business interests, as well three major airports.
Our mission is to develop and commercialize novel tools that:
- Deliver improvements in assisted reproductive technology (ART) in humans and animals
- Facilitate faster identification of individuals for prosecution within the criminal justice system
- Enable advances in life science research and applied markets
- Provide faster, more cost-effective diagnostic solutions for chronically ill patients and their caregivers